Skip to main contentSkip to navigation
Sirius Investors
Avid Bioservices, Inc.

Avid Bioservices, Inc.

CDMO
NASDAQHealthcare

Market Capitalization & Enterprise Value

Research-grade valuation history for CDMO. Track market capitalization versus enterprise value to see the impact of net debt and share changes. Use the interactive chart to explore different horizons; the table updates accordingly to support auditability and export.

Market Cap & Enterprise Value

Comparison of market capitalization and enterprise value over time

Market Cap

Market Capitalization = Stock Price × Number of Shares Outstanding. Represents the total value of a company's equity.
482.21M
164.1x increase over period
CAGR: +19.21%
Compound Annual Growth Rate - The mean annual growth rate over time, accounting for compounding effects.

Enterprise Value

Enterprise Value = Market Cap + Total Debt - Cash and Cash Equivalents. Represents the total value of a company including its debt.
651.94M
201.3x increase over period
CAGR: +20.05%
Compound Annual Growth Rate - The mean annual growth rate over time, accounting for compounding effects.

Market Cap History

Investor Valuation Insights

As of Oct 31, 2024

EV/EBITDA

Distorted

-79.54x

Negative EV/EBITDA usually means negative EBITDA; compare with revenue and cash flow metrics.

EV vs Market Cap Spread

169.73M

EV is +35.2% vs equity value

Capital Structure Signal

Net Debt Profile

EV premium trend: +25.0 pp vs earliest data

Additional Multiples

EV/Sales: 24.13x

Net Debt/EBITDA: -16.94x

Share count change in dataset: +14005.28%

Interpretation guide: EV/EBITDA compares total firm value (debt + equity - cash) to operating earnings. Lower is usually cheaper, but always benchmark against peers, growth rate, margins, and cyclicality.

Market Cap & Enterprise Value Data

Free users can view the latest 3 records. Upgrade to see full history.

Upgrade
DateMarket CapEnterprise ValueStock PriceShares
Apr 30, 2024482.21M651.94M$7.6363.20M
Apr 30, 20231.11B1.26B$17.7662.27M
Apr 30, 2022827.57M883.93M$13.4661.48M
Apr 30, 2021
Apr 30, 2020
Apr 30, 2019
Apr 30, 2018
Apr 30, 2017
Apr 30, 2016
Apr 30, 2015
Apr 30, 2014
Apr 30, 2013
Apr 30, 2012
Apr 30, 2011
Apr 30, 2010
Apr 30, 2009
Apr 30, 2008
Apr 30, 2007
Apr 30, 2006
Apr 30, 2005
Apr 30, 2004
Apr 30, 2003
Apr 30, 2002
Apr 30, 2001
Apr 30, 2000
Apr 30, 1999
Apr 30, 1998
Apr 30, 1997
Apr 30, 1996
Apr 30, 1995

Enterprise Value Analysis

Price Change (Apr 2023 to Apr 2024)

The stock price has decreased from Apr 2023 to Apr 2024.
-57.04%

Recent Volatility

The stock price has been relatively volatile over the last 5 periods, indicating a higher risk profile.
1.22

Risk-Adjusted Return

The stock's returns compensate somewhat for its risk, suggesting a moderate investment opportunity.
0.39

Market Cap Change (Apr 2023 to Apr 2024)

The company's market capitalization has decreased from Apr 2023 to Apr 2024.
-56.40%

Enterprise Value Change (Apr 2023 to Apr 2024)

The company's enterprise value has decreased from Apr 2023 to Apr 2024, suggesting a decline in the company's total economic value.
-48.12%

Market Cap vs. Enterprise Value

A higher enterprise value growth rate compared to market cap growth could indicate that the company is investing heavily in growth initiatives or taking on more debt.
EV Growth > Market Cap Growth

Market Cap CAGR

The Compound Annual Growth Rate (CAGR) of market capitalization represents the mean annual growth rate over the entire available history (30 periods), accounting for compounding effects.
19.21%

Enterprise Value CAGR

The Compound Annual Growth Rate (CAGR) of enterprise value represents the mean annual growth rate over the entire available history (30 periods), accounting for compounding effects.
20.05%